Correo Electrónico
DNINFOA - SIA
Bibliotecas
Convocatorias
Identidad U.N.
Publicado
Scorpion Venom: New Promise in the Treatment of Cancer
Veneno de escorpión: Una nueva promesa en el tratamiento del cáncer
DOI:
https://doi.org/10.15446/abc.v24n2.71512Palabras clave:
Anti-infective agents, antineoplastic agents, Arachnida, molecular biology, peptides (en)Anti-infecciosos, agentes antineoplásicos, Arachnida, biología molecular, péptidos (es)
Descargas
Cancer is a public health problem due to its high worldwide morbimortality. Current treatment protocols do not guarantee complete remission, which has prompted to search for new and more effective antitumoral compounds. Several substances exhibiting cytostatic and cytotoxic effects over cancer cells might contribute to the treatment of this pathology. Some studies indicate the presence of such substances in scorpion venom. In this review, we report characteristics of the principal scorpion venom components found in recent literature and their potential activity against tumor cells. There are different toxin groups present in the venom, and it seems that their mode of actions involves ionic channel blocking, disruption of the cell membrane integrity and damage to internal cell organelles. These properties make good prospects for studies on drugs and adjuvants in cancer treatment.
El cáncer es un problema de salud pública debido a su alta morbimortalidad mundial. Los protocolos de tratamiento actuales no garantizan la remisión completa lo que ha llevado a buscar compuestos antitumorales más efectivos. Varias sustancias que exhiben efectos citostáticos y citotóxicos sobre células tumorales pueden contribuir al diagnóstico y tratamiento de esta patología. Algunos estudios indican la presencia de tales sustancias en el veneno de escorpión. En esta revisión, se dan a conocer las características de los principales componentes del veneno de escorpión encontrados en la literatura reciente y su actividad potencial contra las células tumorales. Existen diferentes grupos de toxinas presentes en el veneno y parece que su modo de acción implica el bloqueo del canal iónico, la alteración de la integridad de la membrana celular y el daño a los orgánulos celulares internos. Estas propiedades ofrecen buenas perspectivas para estudios sobre medicamentos y adyuvantes en el tratamiento del cáncer.
Referencias
Almaaytah A, Albalas Q. Scorpion venom peptides with no disulfide bridges: a review. Peptides. 2014;51:35–45. Doi: https://doi.org/10.1016/j.peptides.2013.10.021
Almaaytah A, Tarazi S, Mhaidat N, Al-Balas Q, Mukattash TL. Mauriporin, a novel cationic alpha-helical peptide with selective cytotoxic activity against prostate cancer cell lines from the venom of the scorpion Androctonus mauritanicus. Int J Pept Res Ther. 2013;19(4):281–293. Doi: https://doi.org/10.1007/s10989-013-9350-3
Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C. Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: Biochemical and functional characterization of natural peptides and a single site-substituted analog. Peptides. 2012;35(2):291–299. Doi: https://doi.org/10.1016/j.peptides.2012.03.016
Aroui S, Ram N, Appaix F, Ronjat M, Kenani A, Pirollet F, et al. Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231. Pharm Res. 2009;26(4):836–845. Doi: https://doi.org/10.1007/s11095-008-9782-1
Baby J, Jency G. Scorpion Toxins and its Applications. Int J Toxicol Pharmacol Res. 2012;4(3):57–61.
Béchohra L, Laraba F, Hammoudi D. Cytotoxic activity of Androctonus australis hector venom and its toxic fractions on human lung cancer cell line. J Venom Anim Toxins Incl Trop Dis. 2016;22(29). Doi: https://doi.org/10.1186/s40409-016-0085-4
BenNasr H, Hammami TS, Zeghal KM. Scorpion Peptides: Potential Use for New Drug Development. J Toxicol. 2013;2013:1–15. Doi: http://dx.doi.org/10.1155/2013/958797
Bloch M, Ousingsawat J, Simon R, Schraml P, Gasser TC, Mihatsch M, et al. KCNMA1 gene mplification promotes tumor cell proliferation in human prostate cancer. Oncogene. 2007;26(17):2525–2534. Doi: http://dx.doi.org/10.1038/sj.onc.1210036
Bordon KC, Wiezel GA, Amorim FG, Arantes EC. Arthropod venom Hyaluronidases: biochemical properties and potential applications in medicine and biotechnology. J Venom Anim Toxins Incl Trop Dis. 2015;(21):43. Doi: https://doi.org/10.1186/s40409-015-0042-7
Brownell P, Polis GA. Scorpion Biology and Research. New York: Oxford University Press; 2001.431 p.
Cascales M. Bases moleculares de la apoptosis. Anal Real Acad Nal Farm. 2003;69(1):36–64.
Catterall WA. Structure and function of voltage-gated sodium channels at atomic resolution. Exp Physiol. 2014;99(1):35-51. Doi: https://doi.org/10.1113/expphysiol.2013.071969
Chippaux JP, Goyffon M. Epidemiology of scorpionism: A global appraisal. Acta Trop. 2008;107(2):71–79. Doi: https://doi.org/10.1016/j.actatropica.2008.05.021
Cociancich S, Goyffon M, Bontems F, Bulet P, Bouet F, Menez A, et al. Purification and characterization of a scorpion defensin, a 4kDa antibacterial peptide presenting structural similarities with insect defensins and scorpion toxins. Biochem Biophys Res Commun. 1993;194(1):17–22. Doi: https://doi.org/10.1006/bbrc.1993.1778
Cohen G, Burks SR, Frank JA. Chlorotoxin—A Multimodal Imaging Platform for Targeting Glioma Tumors. Toxins (Basel). 2018;10(12):496. Doi: https://doi.org/10.3390/toxins10120496
D’Suze G, Rosales A, Salazar V, Sevcik C. Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell line. Toxicon. 2010;56(8):1497-1505. Doi: 10.1016/j.toxicon.2010.09.008
Dai L, Corzo G, Naoki H, Andriantsiferana M, Nakajima T. Purification, structure–function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis. Biochem Biophys Res Commun. 2002;293(5):1514-1522. Doi: https://doi.org/10.1016/S0006-291X(02)00423-0
Das Gupta S, Debnath A, Saha A, Giri B, Tripathi G., Vedasiromoni J, et al. Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. Leuk Res. 2007;31(6):817-825. Doi: https://doi.org/10.1016/j.leukres.2006.06.004
De Souza EM, Cota BB, Almeida FD. Anticancer potential of spider venom. In: Gopalakrishnakone P, Corzo G, Diego-Garcia E, de Lima M, editor(s). Spider Venoms. Toxinology. Springer, Dordrecht; 2015. p.1–15. Doi: https://doi.org/10.1007/978-94-007-6646-4_11-1
Deshane J, Garner CC, Sontheimer H. Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2. J Biol Chem. 2003;278(6):4135-4144. Doi: https://doi.org/10.1074/jbc.M205662200
Díaz A, Morier L, Frión Y, Rodríguez H, Caballero Y, Mendoza D, et al. In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines.J Venom Res.2013;4:5–12.
Díaz A, Ruiz JL, Rodríguez H, Fraga JA. Rhopalurus junceus scorpion venom induces apoptosis in the triple negative human breast cancer cell line MDA-MB-231. J Venom Res. 2017;8:9–13.
Díaz A, Ruiz JL, Yglesias A, Rodríguez H, Riquenes Y, Fleitas O, et al. Enzymatic analysis of venom from Cuban scorpion Rhopalurus junceus. J Venom Res. 2015;(6):11–8.
Ding J, Chua PJ, Bay BH, Gopalakrishnakone P. Scorpion venoms as a potential source of novel cancer therapeutic compounds. Exp Biol Med (Maywood). 2014;239(4):387–393. Doi: https://doi.org/10.1177/1535370213513991
Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, et al. AaeAP1 and AaeAP2: Novel Antimicrobial Peptides from the Venom of the Scorpion, Androctonus aeneas: Structural Characterisation, Molecular Cloning of Biosynthetic Precursor-Encoding cDNAs and Engineering of Analogues with Enhanced Antimicrobial and Anticancer Activities. Toxins. 2015;7(2):219–237. Doi: https://doi.org/10.3390/toxins7020219
Estrada S, Gómez L, Vargas L, van der Meijden A. Characterizing the biological and biochemical profile of six different scorpion venoms from the Buthidae and Scorpionidae family. Toxicon. 2017;130:104-115. Doi: https://doi.org/10.1016/j.toxicon.2017.02.007
Feng L, Gao R, Gopalakrishnakone P. Isolation and characterization of a hyaluronidase from the venom of Chinese red scorpion Buthus martensi. Comp Biochem Physiol C Toxicol Pharmacol. 2008;148(3):250–257. Doi: https://doi.org/10.1016/j.cbpc.2008.06.003
Fernandes M, Félix J, Menezes Y. Chapter 2: Toxins from Venomous Animals: Gene Cloning, Protein Expression and Biotechnological Applications. In: Dr. Gandhi Radis Baptista, editor. An Integrated View of the Molecular Recognition and Toxinology - From Analytical Procedures to Biomedical Applications. InTech. 2013.p.1–50.
Fernandes MF, Félix J, Menezes YA. Toxins from Venomous Animals: Gene Cloning, Protein Expression and Biotechnological Applications. In: Rádis G, editor. An Integrated View of the Molecular Recognition and Toxinology. InTechOpen; 2013.p.23-72. Doi: https://doi.org/10.5772/52380
Fu YJ, Yin LT, Liang AH, Zhang CF, Wang W, Chai BF, et al. Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. Neurosci Lett. 2007;412(1):62–67. Doi: https://doi.org/10.1016/j.neulet.2006.10.056
Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3(9):710–720. Doi: https://doi.org/10.1038/nri1180
Gao R, Zhang Y, Gopalakrishnakone P. Purification and N-terminal sequence of a serine proteinase-like protein (BMK-CBP) from the venom of the Chinese scorpion (Buthus martensii Karsch). Toxicon. 2008; 52(2):348–353. Doi: https://doi.org/10.1016/j.toxicon.2008.06.003
Ghavami S, Asoodeh A, Klonisch T, Halayko A, Kadkhoda K, Kroczak T, et al. Brevinin-2R1 semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Moll Med. 2009;12(3):1005–1022. Doi: https://doi.org/10.1111/j.1582-4934.2008.00129.x
Giovannini C, Baglioni M, Baron M, Cescon M, Bolondi L, Gramantieri L. Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma. Sci Rep. 2017;7:44685. Doi: https://doi.org/10.1038/srep44685.
Gomes A, Bhattacharjee P, Mishra R, Biswas AK, Dasgupta SC, Giri B. Anticancer potential of animal venom and toxin. Indian J Exp Biol. 2010;48(2):93–103.
Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, et al. Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities. Biochimie. 2013;95(9):1784–1794. Doi: https://doi.org/10.1016/j.biochi.2013.06.003
Gupta SD, Gomes A, Debnath A, Saha A, Gomes A. Apoptosis Induction in Human LeukemicCells by a Novel Protein Bengalin, Isolated from Indian Black ScorpionVenom: through Mitochondrial Pathway and Inhibition of Heat Shock Proteins. Chem Biol Interact. 2010;183(2):293–303. Doi: https://doi.org/10.1016/j.cbi.2009.11.006
Guzmán JJ, Ochoa A, López R, López JE. Plant antimicrobial peptides as potential anticancer agents. Biomed Res Int. 2015;2015:735087. Doi: http://dx.doi.org/10.1155/2015/735087
Harrison PL, Abdel-Rahman MA, Miller K, Strong PN. Antimicrobial peptides from scorpion venoms. Toxicon. 2014;88:115–137. Doi: https://doi.org/10.1016/j.toxicon.2014.06.006
Heinen TE, Da Veiga AB. Arthropod venoms and cancer. Toxicon. 2011;57(4):497-511. Doi: https://doi.org/10.1016/j.toxicon.2011.01.002
Howl J, Nicholl ID, Jones S. The many futures for cell-penetrating peptides: how soon is now? Biochem Soc Trans. 2007;35(Pt4):767–769. Doi: https://doi.org/10.1042/BST0350767
Jang SH, Choi SY, Ryu PD, Lee SY. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur J Pharmacol. 2011;651(1-3):26–32. Doi: https://doi.org/10.1016/j.ejphar.2010.10.066
Li B, Lyu P, Xi X, Ge L, Mahadevappa R, Shaw C, et al. Triggering of cancer cell cycle arrest by a novel scorpion venom-derived peptide-Gonearrestide. J Cell Mol Med. 2018;22(9):4460-4473. Doi: https://doi.org/10.1111/jcmm.13745
Liu YF, Hu J, Zhang JH, Wang SL, Wu CF. Isolation, purification, and N-terminal partial sequence of an antitumor peptide from the venom of the Chinese scorpion Buthus martensii Karsch. Prep Biochem Biotechnol. 2002;32(4):317–327. Doi: https://doi.org/10.1081/PB-120015456
Liu Z, Tao J, Ye P, Ji Y. Mining the Virgin Land of Neurotoxicology: A Novel Paradigm of Neurotoxic Peptides Action on Glycosylated Voltage-Gated Sodium Channels. J Toxicol. 2012;2012(5):1-6. Doi: https://doi.org/10.1155/2012/843787
Lizarbe MA. El suicidio y La Muerte Celular. Rev R Acad Cienc Exact Fís Nat. 2007;101(2):1–33.
Lohner K, Blondelle SE. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb Chem High Throughput Screen. 2005;8(3):241–256. https://doi.org/10.2174/1386207053764576
Luna K, Jiménez JM, Possani LD. Scorpine-Like Peptides. Single Cell Biol. 2016;5(138):1-3. Doi: https://doi.org/10.4172/2168-9431.1000138
Luna K, Tonk M, Rahnamaeian M, Vilcinskas A. Bioactivity of Natural and Engineered Antimicrobial Peptides from Venom of the Scorpions Urodacus yaschenkoi and U. manicatus. Toxins (Basel). 2017;9(1):22. Doi: https://doi.org/10.3390/toxins9010022
Mamelak AN, Jacoby DB. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv. 2007;4(2):175–186. Doi: https://doi.org/10.1517/17425247.4.2.175
Martineau Y, Müller D, Pyronnet S. Targeting protein synthesis in cancer cells. Oncoscience. 2014;1(7):484–485. Doi: https://doi.org/10.18632/oncoscience.63
Meng L, Xie Z, Zhang Q, Li Y, Yang F, Chen Z. et al. Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin. J Biol Chem. 2016;291(13):7097–7106. Doi: https://doi.org/10.1074/jbc.M115.680611
Nabi G, Ahmad N, Ullah S, Ghufran Dr., Khan S. Therapeutic Applications of Scorpion Venom in Cancer: Mini Review. J Biol Life Sci. 2014;6(1):57–66. Doi: http://dx.doi.org/10.5296/jbls.v6i1.6418
Narang AS, Desai DS. Anticancer Drug Development. Unique Aspects of Pharmaceutical Development. In: Lu Y, Mahato RI, editors. Pharmaceutical Perspectives of Cancer Therapeutics. Springer Science & Business Media; 2009. p.49–92. Doi: http://dx.doi.org/10.1007/978-1-4419-0131-6_2
Novac O, Guenier AS, Pelletier J. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Nucleic Acids Res. 2004;32(3):902–915. Doi: http://dx.doi.org/10.1093/nar/gkh235
Ortiz E, Gurrola GB, Schwartz EF, Possani LD. Scorpion venom components as potential candidates for drug development. Toxicon. 2015;93:125–135. Doi: http://dx.doi.org/10.1016/j.toxicon.2014.11.233
Possani L, Rodriguez R. Scorpion Venom Peptides. In: Kastin AJ, editor. Handbook of Biologically Active Peptides. Academic Press. Burlington, MA: Elsevier; 2006. p. 339–354. Doi: https://doi.org/10.1016/B978-012369442-3/50054-4
Possani LD, Merino E, Corona M, Bolívar F, Becerril B. Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie. 2000;82(9-10):861–868.
Riedl S, Zweytick D, Lohner K. Membrane- active host defense peptides -- challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids. 2011;164(8):766–781. Doi: https://doi.org/10.1016/j.chemphyslip.2011.09.004
Romero MT, Santibáñez CE, Jiménez JM, Batista CVF, Ortiz E, Possani LD. Transcriptomic and Proteomic Analyses Reveal the Diversity of Venom Components from the Vaejovid Scorpion Serradigitus gertschi. Toxins (Basel). 2018;10(9):359. Doi: https://doi.org/10.3390/toxins10090359
Romero T, Peguero E, Cevallos MA, Batista CVF, Ortiz E, Possani LD. A Deeper Examination of Thorellius atrox Scorpion Venom Components with Omic Technologies. Toxins. 2017;9(12):399 Doi: https://doi.org/10.3390/toxins9120399
Santibáñez CE, Cid-Uribe JI, Batista CV, Ortiz E, Possani LD. Venom Gland Transcriptomic and Proteomic Analyses of the Enigmatic Scorpion Superstitionia donensis (Scorpiones: Superstitioniidae), with Insights on the Evolution of Its Venom Components. Toxins (Basel). 2016;8(12):367. Doi: https://doi.org/10.3390/toxins8120367
Satitmanwiwat S, Changsangfab C, Khanuengthong A, Promthep K, Roytrakul S, Arpornsuwan T, et al. The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells. Biomed Pharmacother. 2016;84:1042–1050. Doi: http://dx.doi.org/10.1016/j.biopha.2016.10.041
Schwab A, Reinhardt J, Schneider SW, Gassner B, Schuricht B. K (+) Channel-Dependent Migration of Fibroblasts and Human Melanoma Cells. Cell Physiol Biochem. 1999;9(3):126–132. Doi: http://dx.doi.org/10.1159/000016309
Shuster S, Frost GI, Csoka AB, Formby B, Stern R. Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer. 2002;102(2):192–197. Doi: https://doi.org/10.1002/ijc.10668
Simons AL, Orcutt KP, Madsen JM, Scarbrough PM, Spitz DR. The Role of Akt Pathway Signaling in Glucose Metabolism and Metabolic Oxidative Stress. In: Spitz D, Dornfeld K, Krishnan K, Gius D, editors. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, Totowa, NJ; 2012. p.21–46. Doi: https://doi.org/10.1007/978-1-61779-397-4_2
Soletti RC, Del Barrio L, Daffre S, Miranda A, Borges HL, Moura-Neto V, et al. Peptide gomesin triggers cell death through L-type channel calcium influx, MAPK/ERK, PKC and PI3K signaling and generation of reactive oxygen species. Chem Biol Interact. 2010;186(2):135–143. Doi: https://doi.org/10.1016/j.cbi.2010.04.012
Sun X, Zhang Y, Jia Q, Wang Z, Zhang W. Effect of polypeptide extract from scorpion venom (PESV) with chemotherapy inhibited angiogenesis of Lewis lung carcinomas. Zhongguo Zhong Yao Za Zhi. 2011;36(12):1644–1649. Doi: https://doi.org/10.4268/cjcmm20111223
Ullrich N, Sontheimer H. Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. Am J Physiol. 1996;270(5):1511–1521. Doi: https://doi.org/10.1152/ajpcell.1996.270.5.C1511.
Vorontsova OV, Egorova NS, Arseniev AS, Feofanov AV. Haemolytic and cytotoxic action of latarcin Ltc2a. Biochimie. 2011;93(2):227–241. Doi: https://doi.org/10.1016/j.biochi.2010.09.016
Wang WX, Ji YH. Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro. J Neurooncol. 2005;73(1):1-7. Doi: https://doi.org/10.1007/s11060-004-4205-6
Weaver AK, Liu X, Sontheimer H. Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res. 2004;78(2):224–234. Doi: https://doi.org/10.1002/jnr.20240
World Health Organization. Cancer fact sheet. [serial online] 2018 Feb. Available in: http://www.who.int/mediacentre/factsheets/fs297/en/. Cited: 19 Mar 2018.
Xu T, Fan Z, Li W, Dietel B, Wu Y, Beckmann MW, et al. Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Sci Rep. 2016;6:19799. Doi: https://doi.org/10.1038/srep19799
Yang JB, Li XW, Dong WH, Kong TH, Song HX, Zheng XY, et al. Effect of anticancer polypeptide from Buthus Martensii venom on immune function in the H22- bearing mice. Zhongguo Zhong Yao Za Zhi. 2000;25(12):736–739.
Yglesias A, Rodríguez H, Díaz A. Synergistic effect of Rhopalurus junceus scorpion venom combined with conventional cytostatics in cervical cancer cell line HeLa. J Pharm Pharmacogn Res. 2019;7(1):67-76.
Zargan J, Sajad M, Umar S, Naime M, Ali S, Khan HA. Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest. Exp Mol Pathol. 2011c;91(1):447–454. Doi: https://doi.org/10.1016/j.yexmp.2011.04.008
Zargan J, Sajad M, Umar S, Naime M, Ali S, Khan HA. Scorpion (Odontobuthus doriae) venom induces apoptosis and inhibits DNA synthesis in human neuroblastoma cells. Mol Cell Biochem. 2011a;348(1-2):173–181. Doi: https://doi.org/10.1007/s11010-010-0652-x
Zargan J, Umar S, Sajad M, Naime M, Ali S, Khan HA. Scorpion venom (Odontobuthus doriae) induces apoptosis by depolarization of mitochondria and reduces S-phase population in human breast cancer cells (MCF-7). Toxicol In Vitro. 2011b;25(8):1748–1756. Doi: https://doi.org/10.1016/j.tiv.2011.09.002
Zhu S, Li W, Jiang D, Zeng X. Evidence for the Existence of Insect Defensin-Like Peptide in Scorpion Venom. IUBMB Life. 2000;50(1):57–61. Doi: https://doi.org/10.1080/15216540050176601
Zhu S, Tytgat J. The scorpine family of defensins: gene structure, alternative polyadenylation and fold recognition. Cell Mol Life Sci. 2004;61(14):1751–1763. Doi: https://doi.org/10.1007/s00018-004-4149-1
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
CrossRef Cited-by
1. Laura A. Lozano-Trujillo, Diana K. Garzón-Perdomo, Andrea C.R. Vargas, Lina M. de los Reyes, Marco F. Avila-Rodriguez, Olivia T.G. Gay, Liliana F. Turner. (2021). Cytotoxic Effects of Blue Scorpion Venom (Rhopalurus junceus) in a Glioblastoma Cell Line Model. Current Pharmaceutical Biotechnology, 22(5), p.636. https://doi.org/10.2174/1389201021666200717092207.
2. Arzu İŞCAN, Figen ÇALIŞKAN, Hatice Mehtap KUTLU, Canan VEJSELOVA SEZER, Hakan ÇALIŞKAN. (2020). Akrep Hemolenfinin Kanser Hücrelerinde Antiproliferatif ve Morfolojik Etkilerinin Araştırılması. Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi, 7(100. Yıl Özel Sayı), p.363. https://doi.org/10.35193/bseufbd.682149.
3. Nabil A. Alhakamy, Usama A. Fahmy, Shaimaa M. Badr Eldin, Osama A. A. Ahmed, Hibah M. Aldawsari, Solomon Z. Okbazghi, Mohamed A. Alfaleh, Wesam H. Abdulaal, Abdulmohsin J. Alamoudi, Fatma M. Mady. (2021). Scorpion Venom-Functionalized Quercetin Phytosomes for Breast Cancer Management: In Vitro Response Surface Optimization and Anticancer Activity against MCF-7 Cells. Polymers, 14(1), p.93. https://doi.org/10.3390/polym14010093.
4. Mohammed W. Al-Rabia, Nabil A. Alhakamy, Waleed Y. Rizg, Adel F. Alghaith, Osama A. A. Ahmed, Usama A. Fahmy. (2022). Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles. Drug Delivery, 29(1), p.807. https://doi.org/10.1080/10717544.2022.2048133.
5. Euridice L. Mejía-Argueta, Jonnathan G. Santillán Benítez, Mariana Ortiz-Reynoso. (2020). Antimicrobial peptides, an alternative to combat bacterial resistance. Acta Biológica Colombiana, 25(2), p.294. https://doi.org/10.15446/abc.v25n2.77407.
6. Valery Gunas, Oleksandr Maievskyi, Tatyana Synelnyk, Nataliia Raksha, Tetiana Vovk, Tetiana Halenova, Olexiy Savchuk, Igor Gunas. (2024). Cytokines and their regulators in rat lung following scorpion envenomation. Toxicon: X, 22, p.100198. https://doi.org/10.1016/j.toxcx.2024.100198.
7. D. B. Pereira, J. G. Martins, M. S. Oliveira, R. S. Lima-Júnior, L. C. Rocha, S. L. Andrade, R. E. L. Procópio. (2023). Leishmanicidal activity of the venoms of the Scorpions Brotheas amazonicus and Tityus metuendus. Brazilian Journal of Biology, 83 https://doi.org/10.1590/1519-6984.276872.
8. Rym ElFessi, Oussema Khamessi, Michel De Waard, Najet Srairi-Abid, Kais Ghedira, Riadh Marrouchi, Riadh Kharrat. (2024). Structure–Function Relationship of a Novel MTX-like Peptide (MTX1) Isolated and Characterized from the Venom of the Scorpion Maurus palmatus. International Journal of Molecular Sciences, 25(19), p.10472. https://doi.org/10.3390/ijms251910472.
9. Nooshin Ghadiri, Vida Homayouni, Zahra Akbari Jonoush, Roya Mahdavi, Nastaran Mohammadi, Amir Mohamad Amiri, Mahdieh Sadat Badiee, Mazdak Ganjalikhani Hakemi. (2026). Therapeutic Potential of Scorpion Venom Proteins: Innovations in Cancer Treatment and Future Directions. Current Drug Targets, 27(1), p.33. https://doi.org/10.2174/0113894501396738250904071722.
10. Yenny Yolanda Lozano Jiménez, Juan Daniel Hernández Vargas, David Mateo Navarrete Benavides, Ruth Mélida Sánchez Mora. (2025). Use of spheroids as a model to evaluate the anticancer action of animal venoms and derived molecules: 2010-2024 review. Journal of Venomous Animals and Toxins including Tropical Diseases, 31 https://doi.org/10.1590/1678-9199-jvatitd-2024-0068.
11. Ismail Atia, Mohsen A Moustafa, Omar S.O. Amer, Alaa MH El-Bitar, Naser Abdelsater. (2025). The role of scorpion, Leiurus quinquestriatus, and bee, Apis mellifera crude venoms in controlling schistosomal activity of Swiss Albino mice. New Horizons Journal of Basic and Applied Sciences, , p.15. https://doi.org/10.62184/nhjbas.jnh10020252.
12. Dimitrios G. Boucharas, Chryssa Anastasiadou, Spyridon Karkabounas, Efthimia Antonopoulou, George Manis. (2024). Toward Cancer Chemoprevention: Mathematical Modeling of Chemically Induced Carcinogenesis and Chemoprevention. BioMedInformatics, 4(1), p.360. https://doi.org/10.3390/biomedinformatics4010021.
13. Humaira Hassan, Munazza Raza Mirza, Almas Jabeen, Mehtab Alam, Junaid Ahmed Kori, Rabia Sultan, Saeed ur Rahman, M. Iqbal Choudhary, Samiullah Khan. (2024). Yellow scorpion (Buthus sinidicus) venom peptides induce mitochondrial-mediated apoptosis in cervical, prostate and brain tumor cell lines. PLOS ONE, 19(2), p.e0296636. https://doi.org/10.1371/journal.pone.0296636.
14. Shirin Ahmadi, Julius M. Knerr, Lídia Argemi, Karla C. F. Bordon, Manuela B. Pucca, Felipe A. Cerni, Eliane C. Arantes, Figen Çalışkan, Andreas H. Laustsen. (2020). Scorpion Venom: Detriments and Benefits. Biomedicines, 8(5), p.118. https://doi.org/10.3390/biomedicines8050118.
15. R. Suhas. (2022). Structure, function and mechanistic aspects of scorpion venom peptides - A boon for the development of novel therapeutics. European Journal of Medicinal Chemistry Reports, 6, p.100068. https://doi.org/10.1016/j.ejmcr.2022.100068.
16. Masoumeh Baradaran. (2025). Promising Venom-derived Peptides as Innovative Health Solutions for Treating the Metabolic Disorders: A Policy Brief. Jundishapur Journal of Natural Pharmaceutical Products, 20(3) https://doi.org/10.5812/jjnpp-163296.
Dimensions
PlumX
Visitas a la página del resumen del artículo
Descargas
Licencia
Derechos de autor 2019 Acta Biológica Colombiana
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
1. La aceptación de manuscritos por parte de la revista implicará, además de su edición electrónica de acceso abierto bajo licencia Attribution-NonCommercial-ShareAlike 4.0 (CC BY NC SA), la inclusión y difusión del texto completo a través del repositorio institucional de la Universidad Nacional de Colombia y en todas aquellas bases de datos especializadas que el editor considere adecuadas para su indización con miras a incrementar la visibilidad de la revista.
2. Acta Biológica Colombiana permite a los autores archivar, descargar y compartir, la versión final publicada, así como las versiones pre-print y post-print incluyendo un encabezado con la referencia bibliográfica del articulo publicado.
3. Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
4. Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos institucionales, en su página web o en redes sociales cientificas como Academia, Researchgate; Mendelay) lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
